217 related articles for article (PubMed ID: 34285345)
1. A pan-cancer analysis of alternative splicing of splicing factors in 6904 patients.
Cheng R; Xiao L; Zhou W; Jin X; Xu Z; Xu C; Wang P; Luo M; Wang M; Ma K; Cao H; Huang Y; Lin X; Pang F; Li Y; Jiang Q
Oncogene; 2021 Sep; 40(35):5441-5450. PubMed ID: 34285345
[TBL] [Abstract][Full Text] [Related]
2. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.
Venkataramany AS; Schieffer KM; Lee K; Cottrell CE; Wang PY; Mardis ER; Cripe TP; Chandler DS
Ann Oncol; 2022 Jun; 33(6):578-592. PubMed ID: 35339647
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing in cancers: From aberrant regulation to new therapeutics.
Song X; Zeng Z; Wei H; Wang Z
Semin Cell Dev Biol; 2018 Mar; 75():13-22. PubMed ID: 28919308
[TBL] [Abstract][Full Text] [Related]
4. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
5. LncAS2Cancer: a comprehensive database for alternative splicing of lncRNAs across human cancers.
Deng Y; Luo H; Yang Z; Liu L
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32820322
[TBL] [Abstract][Full Text] [Related]
6. OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers.
Zhang Y; Yao X; Zhou H; Wu X; Tian J; Zeng J; Yan L; Duan C; Liu H; Li H; Chen K; Hu Z; Ye Z; Xu H
Nucleic Acids Res; 2022 Jan; 50(D1):D1340-D1347. PubMed ID: 34554251
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of non-coding RNA-modulated alternative splicing in cancer.
Wang X; Hua J; Li J; Zhang J; Dzakah EE; Cao G; Lin W
RNA Biol; 2022; 19(1):541-547. PubMed ID: 35427215
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing and cancer: a systematic review.
Zhang Y; Qian J; Gu C; Yang Y
Signal Transduct Target Ther; 2021 Feb; 6(1):78. PubMed ID: 33623018
[TBL] [Abstract][Full Text] [Related]
10. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
Kahles A; Lehmann KV; Toussaint NC; Hüser M; Stark SG; Sachsenberg T; Stegle O; Kohlbacher O; Sander C; ; Rätsch G
Cancer Cell; 2018 Aug; 34(2):211-224.e6. PubMed ID: 30078747
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer analysis of clinical relevance of alternative splicing events in 31 human cancers.
Zhang Y; Yan L; Zeng J; Zhou H; Liu H; Yu G; Yao W; Chen K; Ye Z; Xu H
Oncogene; 2019 Oct; 38(40):6678-6695. PubMed ID: 31391553
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing.
Li T; Liu Q; Garza N; Kornblau S; Jin VX
Genome Med; 2018 Apr; 10(1):30. PubMed ID: 29665865
[TBL] [Abstract][Full Text] [Related]
15. Robust and annotation-free analysis of alternative splicing across diverse cell types in mice.
Benegas G; Fischer J; Song YS
Elife; 2022 Mar; 11():. PubMed ID: 35229721
[TBL] [Abstract][Full Text] [Related]
16. Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer.
Han J; An O; Ren X; Song Y; Tang SJ; Shen H; Ke X; Ng VHE; Tay DJT; Tan HQ; Kappei D; Yang H; Chen L
Nat Commun; 2022 Apr; 13(1):1793. PubMed ID: 35379802
[TBL] [Abstract][Full Text] [Related]
17. Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity.
Liu X; Wang Y; Chang G; Wang F; Wang F; Geng X
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272339
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
Tsai YS; Dominguez D; Gomez SM; Wang Z
Oncotarget; 2015 Mar; 6(9):6825-39. PubMed ID: 25749525
[TBL] [Abstract][Full Text] [Related]
19. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
[TBL] [Abstract][Full Text] [Related]
20. MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors.
Urbanski L; Brugiolo M; Park S; Angarola BL; Leclair NK; Yurieva M; Palmer P; Sahu SK; Anczuków O
Cell Rep; 2022 Nov; 41(8):111704. PubMed ID: 36417849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
